NYU Langone Medical Center
530 First Avenue
Faculty Practice Offices 7R
New York, NY 10016
(212) 263-5889
False Creek Clinic
555 West 8th Avenue
Vancouver, BC V5Z 1C6
(604) 739-9695
(800) 815-9338
Articles, Publications & Books
 

Journals Articles:


Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study
Chu, Thomas Waitao; AlJasser, Mohammed; Alharbi, Aymen; Abahussein, Othman; McElwee, Kevin; Shapiro, Jerry; Journal of the American Academy of Dermatology. 2015:73(2):338-340
 
Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Goren, Andy; Lotti, Torello; Mccoy, John; Roberts, Janet; Desai, Nisha; Shapiro, Jerry; Journal of the American Academy of Dermatology. 2015:72(5)
 
Dermatologic therapy. 2015:28(1):13-16
Clinical utility and validity of minoxidil response testing in androgenetic alopecia
Goren, Andy; Shapiro, Jerry; Roberts, Janet; McCoy, John; Desai, Nisha; Zarrab, Zoulikha; Pietrzak, Aldona; Lotti, Torello


Scarring alopecias: a trichologic emergency
Siah, Tee W; Shapiro, Jerry
Seminars in cutaneous medicine & surgery. 2015:34(2):76-80

Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination
Journal of the American Academy of Dermatology.2014:71(3):415
Mubki, Thamer; Rudnicka, Lidia; Olszewska, Malgorzata; Shapiro, Jerry
 
Evaluation and diagnosis of the hair loss patient: part II. Trichoscopic and laboratory evaluationsJournal of the American Academy of Dermatology. 2014:71(3):431
Mubki, Thamer; Rudnicka, Lidia; Olszewska, Malgorzata; Shapiro, Jerry

Journal of investigative dermatology. 2014:134 1 1:S24-S24.DOI:
Successful treatment of discoid lupus erythematosus with tacrolimus 0.3% solution
Ramachandran, S.; Shapiro, J.; Franks, A. G.
 
Journal of drugs in dermatology : JDD. 2014:13(11):1308-1310.DOI:
Update on Male Pattern Hair Loss
Santos, Leopoldo Duailibe Nogueira; Shapiro, JerryEvaluation and Diagnosis of the Hair Loss Patient.

Frontal fibrosing alopecia: a retrospective clinical review of 62 patients with treatment outcome and long-term follow-up.Banka N, Mubki T, Bunagan MJ, McElwee K, Shapiro J. Int J Dermatol. 2014 Apr 16.

Current treatment of alopecia areata. Shapiro J. J Investig Dermatol Symp Proc. 2013 Dec;16(1):S42-4.

Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege.Wang X, Marr AK, Breitkopf T, Leung G, Hao J, Wang E, Kwong N, Akhoundsadegh N, Chen L, Mui A, Carr N, Warnock GL, Shapiro J, McElwee KJ. J Invest Dermatol. 2014 Mar;134(3):736-45

Topical agents for hair growth promotion: what is out there? Shamsaldeen OS, Al Mubki T, Shapiro J.Skin Therapy Lett. 2013 Jun;18(4):5-7

Examining the relationship between alopecia areata, androgenetic alopecia, and emotional intelligence.Monselise A, Bar-On R, Chan L, Leibushor N, McElwee K, Shapiro J.J Cutan Med Surg. 2013 Jan-Feb;17(1):46-51.

Somatostatin expression in human hair follicles and its potential role in immune privilege.Breitkopf T, Lo BK, Leung G, Wang E, Yu M, Carr N, Zloty D, Cowan B, Shapiro J, McElwee KJ.J Invest Dermatol. 2013 Jul;133(7):1722-30.

Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice.Wang E, Chong K, Yu M, Akhoundsadegh N, Granville DJ, Shapiro J, McElwee KJ. PLoS One. 2013 Apr 26;8(4):

Pattern hair loss in men: diagnosis and medical treatment. Banka N, Bunagan MJ, Shapiro J. Dermatol Clin. 2013 Jan;31(1):129-40

Hair transplantation update: procedural techniques, innovations, and applications.Bunagan MJ, Banka N, Shapiro J. Dermatol Clin. 2013 Jan;31(1):141-53

A spectrum of hair topics. Guest Editor, Shapiro J. Dermatol Clin. 2013 Jan;31(1):

Examining the relationship between alopecia areata, androgenetic alopecia, and emotional intelligence.Monselise A, Bar-On R, Chan L, Leibushor N, McElwee K, Shapiro J. J Cutan Med Surg. 2013 Jan-Feb;17(1):46-51

Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth. PLoS One. 2012;7(5):e34185. Epub 2012 May 16

Assessment of hair density and caliber in Caucasian and Asian female subjects with female pattern hair loss by using folliscope. J Am Acad Dermatol 2012 Jan;66(1):166-7.

Inner canthus hypertrichosis: a side effect of prostaglandin analogue treatment for glaucoma. J Cutan Med Surg. 2011 Sep-Oct;15(5):298-9.

CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes. Br J Dermatol. 2011 Nov;165(5):1030-1036.

What Ages Hair?, Cosmetic Dermatology, (in press)

Hair Diseases (Guest Editor), Canadian Dematologic Association Bulletin: The Hair Issue, 2011 Oct.

Dermatologic therapy: Alopecia areata update. Dermatol Ther. 2011 May-Jun;24(3):301.

Treatment of Alopecia Areata(Guest Editor), Dermatol Ther. 2011 May-Jun; 24(3).

Break dancing: a new risk factor for scarring hair loss. J Cutan Med Surg. 2011 May-Jun;15(3):177-9.

Central hair loss in African American women: Incidence and potential risk factors. J Am Acad Dermatol. 2011 Feb;64(2):245-521.

Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markers. J Eur Acad Dermatol Venereol. 2010 Nov;24(11):1304-11.

Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol.  2010 Nov;130(11):2677-80.

CXCR3/Ligands are significantly involved in the tumorigenesis of basal cell carcinomas. Am J Pathol.  2010 May;176(5):2435-46.

Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol.  2010 Feb;62(2):177-88, quiz 89-90.

Alopecia areata update: part II. Treatment. J Am Acad Dermatol.  2010 Feb;62(2):191-202, quiz 3-4.

Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray. J Dermatol Sci. 2010 Jan;57(1):27-36.

Successful hair re-growth with multimodal treatment of early cicatricial alopecia in discoid lupus erythematosus. Acta Derm Venereol. 2009;89(4):417-8.

Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study. Arch Dermatol. 2009 Nov;145(11):1262-6.

European Consensus on the evaluation of women presenting with excessive hair growth. Eur J Dermatol. 2009 Nov-Dec;19(6):597-602.

Folliculitis decalvans developing 20 years after hair restoration surgery in punch grafts: case report. Dermatol Surg. 2009 Nov;35(11):1852-6

Management of hirsutism. Skin Therapy Lett. 2009 Sep;14(7):1-3.

Uncombable hair syndrome. J Am Acad Dermatol. 2009 Sep;61(3):512-5.

Successful treatment of temporal triangular alopecia by hair restoration surgery using follicular unit transplantation. Dermatol Surg. 2009 Aug;35(8):1307-10.

Two sisters, two different hair shaft abnormalities. Br J Dermatol. 2009 Aug;161(2):479-80.

Discoid lupus erythematosus presenting with cysts, comedones, and cicatricial alopecia on the scalp. J Am Acad Dermatol. 2009 Jun;60(6):1070-2.

Androgens and hair loss. Curr Opin Endocrinol Diabetes Obes. 2009 Jun;16(3):246-53.

Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol. 2009 Jun;129(6):1527-38.

Efficacy of a day-care program in the treatment of psoriasis. J Cutan Med Surg. 2008 Sep-Oct;12(5):211-6.

Pseudopelade of Brocq. Dermatol Ther. 2008 Jul-Aug;21(4):257-63.

Central scalp alopecia photographic scale in African American women. Dermatol Ther. 2008 Jul-Aug;21(4):264-7.

Secondary cicatricial and other permanent alopecias. Dermatol Ther. 2008 Jul-Aug;21(4):279-94.

Cicatricial alopecias. Dermatol Ther. 2008 Jul-Aug;21(4):211.

Folliculitis decalvans. Dermatol Ther. 2008 Jul-Aug;21(4):238-44.

Lichen planopilaris. Dermatol Ther. 2008 Jul-Aug;21(4):249-56.

Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. J Invest Dermatol. 2008 Jul;128(7):1797-805.

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008 Apr;93(4):1105-20.

Diagnosis and management of primary cicatricial alopecia: part II. Skinmed. 2008 Mar-Apr;7(2):78-83.

Diagnosis and management of primary cicatricial alopecia: part I. Skinmed 2008 Jan-Feb;7(1):19-26.

Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study. Dermatology. 2008;217(2):107-13.

Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties. Exp Dermatol 2008 Jan;17(1):12-9.

Clinical practice. Hair loss in women. N Engl J Med Oct 18, 2007;357(16):1620-30.

Does a practicing dermatologist need to use the Internet? Med Surg Dermatol (Commentary) 1997;4:219-222.

Unwanted facial hair: affects, effects and solutions. Dermatology 2007;215(2):139-46.

A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women.  J Am Acad Dermatol, Jul 2007;57(1):54-9.

Androgenetic alopecia. Endocrinol Metab Clin North Am. Jun 2007;36(2):379-98.

Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 2006;8(14):1-19.

Hair follicles and their role in skin health. Expert Rev Dermatol 2006;1(6)855-71.

Evidence based hair restoration: designing clinical trials. Hair Transplant Forum International. May/June 2006;85-9.

Alopecia areata: pathogenesis and potential for therapy.  Expert Rev Mol Med 2006;8(14):1-19.

Treatments for unwanted facial hair. Skin Therapy Lett 2005;10(10):1-4.

What can we learn from animal models of alopecia areata? Dermatology 2005;211:47-53.

Rapp-Hodgkin syndrome: A review of the aspects of hair and hair color. J Am Acad Dermatol 2005;53(4):729-35.

Paradoxical hypertrichosis and pseudo-hypertrichosis following laser epilation. J Am Acad Dermatol 2005; 53:85-88.

Update on primary cicatricial alopecias.  J Am Acad Dermatol 2005;53(1):1-37; quiz 38-40.

Evaluation and treatment of male and female pattern hair loss.  J Am Acad Dermatol 2005;52:301-11.

Management of hair loss.  Dermatologic Clinics 2005;23(2):227-43.

A practical approach to nonscarring alopecia: female pattern hair loss and telogen effluvium. Contemporary Dermatology 2004;2(2).

A practical approach to nonscarring alopecia: male pattern hair loss. Contemporary Dermatology 2004;2(1).

Alopecia areata investigational assessment guidelines-Part II. J Am Acad Dermatol 2004; 51(3):440-7.

Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.  Arch Dermatol 2004; 140(6):677-83.

Primary cicatricial alopecias - a clinico-pathologic review of 112 cases.  J Am Acad Dermatol 2004; 50:25-32.

Restoration of hair growth in mice with an alopecia areata like disease using topical anthralin.  Exper Dermatol 2004; 13(1):5-10.

Cytokines and signal transduction pathways mediated by anthralin in alopecia areata-affected Dundee experimental balding rats.  J Invest Dermatol Symp Proc 2003;8:87-90.

Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with alopecia areata-like disease by targeting infiltrated lymphocytes.  J Invest Dermatol 2003; 120(3): 400-406.

Cytokines and signal transduction pathways mediated by anthralin in alopecia areata-affected DEBR rats.  J Invest Dermatol Symp Proc 2003; 8(1):87-90.

Restoration of hair growth with topical diphencyprone in murine and rate models of alopecia areata. J Am Acad Dermatol 2003; 49:1013-1019.

Computerized morphometry and three-dimensional image reconstruction in the evaluation of scalp biopsy from patients with non-cicatricial alopecias.  Brit J Dermatol 2003; 148(2):272-8.

Old wine in new bottles: Reviving old therapies for alopecia areata using rodent models.  J Invest Dermatol 2003; 8(2).

Use of finasteride in the treatment of men with androgenitic alopecia (male pattern hair loss).  J Invest Dermatol Symp Proc 2003; 8:20-23.

Safety of topical minoxidil solution.  J of Cutan Med Surg.  Published online 28 July 2003.

The expression of insulin-like growth factor in follicular dermal papillae correlates the therapeutic efficacy of Finasteride in androgenetic alopecia.  J Am Dermatol 2003; 49(2):229-233.

Topical mechloethamine restores autoimmune-arrested follicular activity in mice with alopecia areata-like disease by targeting infiltrated lymphocytes. J Invest Dermatol 2003; 120:400-406.

Topical nitrogen mustard in the treatment of alopecia areata. J Am Acad Dermatology. 2003; 49(2):291-294.

Regeneration of a new hair follicle from the upper half of human hair follicle in nude mouse.  J Invest Dermatol 2002; 119:983-984.

Using the internet to assess and teach medical students in dermatology.  J Cutan Med Surg 2002; 6:315-319.

Vaniqa--eflornithine 13.9% cream.  Skin Therapy Letter 2001;6(7):1-3.

The treatment of alopecia areata.  Dermatologic Therapy 2001;14:1-10.

Alopecia Areata.  In: Sperling L et al. (Eds.), eMedicine Dermatology.  St. Petersburg: eMedicine Corporation, 2001.

The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.  J Am Acad Dermatol 2001;45:665-74.

A predictive model for immunotherapy of alopecia areata with diphencyprone.  Arch Dermatol 2001;137:1063-8.

DPCP for the treatment of alopecia areata.  Skin Therapy Letter 2000;5(5):3-4.

Practical management of hair loss.  Canadian Family Physician 2000;46:1469-1477.

Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. Br J Dermatol 2000;143:1032-1035.

Management of androgenetic alopecia: A review.  Am J Clin Dermatol 2000;1:15-158.

Alopecia areata Update.  J Am Acad Dermatol 2000;42:549-566.

Androgenetic alopecia.  New approved and unapproved treatments.  Dermatologic Clinics 2000;18(1):47-61.

Pseudopelade of Brocq in beard area.  J Am Acad Dermatol 2000;42:895-896.

(Guest Editor) Hair disorders.  J Cutan Med Surg 1999(3).

Alopecia areata-like hair loss in C3H/H3J mice and DEBR rats can be reversed using topical diphencyprone.  J Invest Dermatol 1999;4:239.

Hair disorders:  Patient presentation in the Practical Hair Workshop.  J Cutan Med Surg 1999;3(3):S3-32.

Therapeutic approach to alopecia areata.  J Cutan Med Surg 1999;3(3):S3-36.

Scarring alopecia.  J Cutan Med Surg 1999;3(3):S3-45.

Therapeutic approach to androgenetic alopecia.  J Cutan Med Surg 1999;3(3):S3-26.

Alopecia areata:  Topical immunotherapy - application and practical problems.  J Cutan Med Surg 1999;3(3):S3-40.

Alopecia areata:  diagnosis and management.  Int J Dermatol 1999;38(1):19-24.

The scalp biopsy:  making it more efficient.  Dermatologic Surgery 1999;25:537-538.

Alopecia areata investigational assessment guidelines.  J Am Acad Dermatol 1999;40:242-6.

Plaque type multinucleate cell angiohistocytoma.  J Cutan Med Surg 1998;3(2):112-114.

Finasteride in the Treatment of Men with Androgenetic Alopecia.  J Am Acad Dermatol 1998;39:578-89.

Hair Regrowth, Therapeutic Agents.  Dermatologic Clinics 1998;16(2):341-356.

Systemic cyclosporine and low dose prednisone in the treatment of chronic severe alopecia areata. J Am Acad Dematol 1997;36:114-7.

Topical immunotherapy in the treatment of alopecia areata. Dermatologic Clinics, 11(3):611-617, July 1993.

Alopecia Areata: practical management for the 1990s. Can J Derm 5(3):413-420, May/June 1993.

Alopecia areata: Update on therapy.  Dermatologic Clinics 11(1):35-46,1993.

Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil.  J Am Acad of Dermatol 1993, 29:5;729-735. 

Diphencyprone in alopecia areata. Proceedings of the Cutaneous Biology Foundation Meeting. Aspen Colorado, July 1992.

Erythema chronicum migrans of Lyme disease.  Canadian J Derm 2:3;49-50,  June/July 1990.

Book Reviews: Trends to Human Hair Growth and Alopecia Research.  Canadian J Derm 2:3 June/July 1990.

Androgenetic Alopecia: Pathophysiology and Medical Management.  Canadian J Derm 1989; 1:5;113-119.

 

Abstracts

Nucelotide excision repair (NER) gene family play an important role in the control of non-pigmented hair fiber growth. J Invest Dermatol 2010; 130; S143.

CXCR ligand CXCL11 promotes proliferation of primary basal cell carcinoma cells in vitro. J Invest Dermatol 2010; 130; S26.

Development of alopecia areata may be associated with heart disease. J Invest Dermatol 2010; 130; S1.

Effects of finasteride on female pattern hair loss. Exp Dermatol 2010; 19: 580.

The association of alopecia areata development with cardiac dysfunction. Exp Dermatol 2010; 19: 604.

Deficiency in nucleotide excision repair (NER) family gene activity is associated with nonpigmented hair fiber growth. Exp Dermatol 2010; 19: 566.

Deficiency in nucleotide excision repair (NER) family gene activity, especially lack of ERCC3 activity, is associated with nonpigmented hair fiber graying. Pigment Cell Melanoma Res; 2010; 23: 712.

Microarray analysis of lichen planopilaris and pseudopelade of Brocq suggest they are distinct entities. Int J Trichol 2009; 1: 52.

Hair follicles from alopecia areata patients exhibit immune privilege deficiencies in advance of hair loss. J Invest Dermatol 2009; 129(suppl 2): S69.

Ectodysplasin receptor Edar is highly expressed in nodular basal cell carcinomas. J Invest Dermatol 2009; 129: S26.

Indoleamine-pyrrole 2,3-dioxygenase (IDO) expression may contribute to immunoprotection in basal cell carcinomas. J Invest Dermatol 2009; 129: S25.

Basal cell carcinoma gene expression profiles resemble hair follicles but with significant differences in specific pathway activation. J Invest Dermatol 2008; 128: S27.

The etiopathologic roles of CXCR3/ligands in the tumorigenesis of basal cell carcinomas. J Invest Dermatol 2008; 128: S27.

Gene expression features of Lichen Planopilaris (LPP) and Pseudopelade de Brocq. J Invest Dermatol 2008; 128: S6.

Cytokine mediated growth inhibition rather than cell mediated apoptosis may be the dominant effector mechanism of alopecia areata in the C3H/HeJ mouse model. J Invest Dermatol 2008; 128: S6.

Gene expression profiling reveals differences between different subtypes of basal cell carcinoma. J Invest Dermatol 2007; 127: S21.

The Inflammatory Response to Basal Cell Carcinomas. J Invest Dermatol 2007;127:S20.

Cytokines in alopecia areata: a study of key cytokines in the C3H/HeJ alopecia areata mouse model. J Invest Dermatol 2007;127:S9.

Clinical studies in hair transplantation using digital imaging. Dermatology 2006; 213: 74.

Hair growth modulatory properties of IL-6 cytokine family members. J Invest Dermatol 2006; 126(suppl):96.

Microarray analysis of gene expression in basal cell carcinomas. J Invest Dermatol 2006;126(suppl):14.

Gene expression profiling reveals differences between different subtypes of basal cell carcinoma. J Invest Dermatol 2007;127:S21.

Effectiveness of psoriasis treatment in a day care program: a PASI analysis. J Invest Dermatol Supplement April 2006;126(4):259.

Hair growth modulatory properties of IL-6 cytokine family members.  JID Supplement April 2006;126(4):571.

Computer-assisted histomorphometric evaluation of scalp biopsies.  J Cutan Med Surg 2001;5:49.

Restoration of hair growth with topical anthralin in alopecia areata rats:  Efficacy and molecular mechanisms.  J Cutan Med Surg 2001;5:48.

Efficacy of narrow-band UVB in the treatment of alopecia areata.  J Cutan Med Surg 2000;4(July):22.

A comparative study of tolerance to narrow band and broad band UVB as assessed by serial phototesting during psoriasis phototherapy.  Photomedicine Society Meeting, Louisiana, March 1999.

Soluble factors of follicular dermal papilla arrest cell cycle and induce differentiation in follicular keratinocytes.  J Invest Dermatol 1999;112:642.

Leflunomide in the alopecia areata DEBR rat.  Third International Research Workshop on Alopecia Areata, Washington, DC, November 1998.

Two-year study of finasteride in the treatment of men with androgenetic alopecia.  J Cutan Med Surg 1998;3 (suppl):19.

Treatment of chronic severe alopecia areata with low dose systemic cyclosporine and prednisone. Poster presentation, Tricontinental Hair Research Societies Meeting, Brussels, October 1995.

Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: A clinical and immunopathologic evaluation. JID Supplement May 1995;104(5):37.

Systemic cyclosporine and low dose prednisone in the treatment of chronic severe alopecia areata. JID 1995;104(4):662.

BCL-2 expression in severe chronic alopecia areata.  JID 1994;102(4):611.

Topical Immunotherapy with Diphencyprone for severe alopecia areata: results of a Canadian trial.  3rd Congress of European Academy of Dermatology and Venereology. September 1993.  Copenhagen, Denmark.

Diphencyprone and minoxidil in alopecia areata: A clinical and immunopathologic evaluation. JID 1992;98(4):562.

Leflunomide in the Alopecia Areata DEBR Rat.

Overexpression of transcription factor AP-1 effects steroid responsiveness in alopecia areata. JID 104;(4):606.

 

Books

Hair Loss: Principles of Diagnosis and Management of Alopecia.  Martin Dunitz Ltd. 2002.

Alopecia Areata - Understanding and Coping with Hair Loss. Johns Hopkins Press, Baltimore. 1996.

 

Chapters

Chapter 88: Hair growth disorders. In: Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill (2012).

Possibilities and limitations for reversal of age related hair loss. In: Aging hair. Trüeb RM, Tobin D (Eds). Springer, Heidelberg, Germany (2011).

Current view on the pathogenesis of patterned hair loss. In: Hair transplantation, 5th Ed. Unger WP, Shapiro R, Unger MA (Eds). Informa Healthcare USA, Inc., New York, NY (2011).

Secondary cicatricial alopecia. In: Hair from Basic Science to Clinical Application. Tosti, Whiting (Eds). Springer Verlag 2007.

Primary cicatricial alopecia. In: Textbook on Hair from Basic Science to Clinical Application. Tosti, Whiting (Eds). Springer Verlag 2007.

Diseases of the Hair.  In: Conn's Current Therapy Textbook 2001.  W.B. Saunders.  2001.

Hair Loss.  In: McGraw-Hill 2001 Yearbook of Science and Technology.  2000

Alopecia: Unapproved medications or indications.  Clinics in Dermatology 2000;18:177-86.

New therapeutic directions.  In: Camacho, Randall, Price (Eds), Hair Biology and Disorders:  Research, Pathology and Management.  Dunitz. 1999.

Common Hair Loss Disorders. In: Atlas of Hair and Nails. Hordinsky M, Sawaya M. Scher R (Eds). Churchill Livingstone. 1999;91-103.

Systemic cyclosporine and low dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. In: DJ Van Neste, VA Randall (eds) Hair Research for the Next Millennium, Elsevier Science. 1996;279-280.

Medicated shampoos. Clinics in Dermatology, 1996;14:123-128.

Diseases of the Hair.  In: Conn's Current Therapy, 1996, pgs 739-741. Ed. Robert E. Rakel, W.B. Saunders Co.

Back to Top